Study: FDA, Drug Makers Allowed Prescribing of Fentanyl to Ineligible Patients


A new study concludes the U.S. Food and Drug Administration (FDA) and drug manufacturers allowed the widespread prescribing of a fentanyl painkiller to ineligible patients.

The study found the FDA and drug companies ignored evidence that as many as half of patients taking the drugs should not have been prescribed them, and did not review prescribing records of any doctors to consider disqualifying them from a monitoring program designed to safeguard the drugs’ use.

The study was based on a review of almost 5,000 pages of documents obtained from the government through the Freedom of Information Act, The Washington Post reports.

“Both the FDA and the fentanyl makers failed to design and implement an effective monitoring program,” study senior author G. Caleb Alexander, MD of the Johns Hopkins Bloomberg School of Public Health said in a news release.

How Can I Protect My Child from Fentanyl? 5 Things Parents Need to Know

Deaths from fentanyl rose a staggering 72% in just one year. If your son or daughter has an opioid addiction, here are five things to know to keep your child safe.

fentanyl and heroin - two potentially fatal dosages

Leave a Comment

Please leave a comment below to contribute to the discussion. If you have a specific question, please contact a Parent Specialist, who will provide you with one-on-one help.

Your email address will not be published. Required fields are marked *